Advertisement
(Logo: http://photos.prnewswire.com/prnh/20131206/CG29153LOGO)
Current data suggests that H7N9 is not easily spread by person-to-person contact but rather by exposure to infected poultry or to the contaminated environment where the infected birds have been maintained. According to the CDC, the concern is that the H7N9 virus will change in such a way that the virus gains the ability to spread easily and sustainably among people triggering a global pandemic. The 2009 H1N1 pandemic occurred due to such a change that created a new virus which humans had little or no immunity against. For this reason, it is important to have antimicrobial products available that have proven efficacy against H7N9.
Advertisement
"As the leader in virucidal efficacy testing, ATS Labs is excited to include H7N9 in our library of more than 200 different virus strains to help combat this potential public health threat" states Thomas Burnell, PhD, Executive Chairman of ATS Labs. "The addition of H7N9 to our list of influenza viruses, including H5N1 and H1N1, provides developers of antimicrobial products with comprehensive options to help support their product registrations within the United States, Canada, and abroad".
About ATS Labs
With over 25 years of specialized microbiology and virology testing experience, ATS Labs is the preferred antimicrobial, microbial identification and analytical chemistry test laboratory for the developers, manufacturers, and users of antimicrobial products. ATS Labs is an innovative company dedicated to providing the highest quality testing services to the antimicrobial industry while offering our clients the highest level of scientific and regulatory expertise with superior customer service.
To learn more about the comprehensive testing services offered by ATS Labs, please visit http://www.ats-labs.com.
Contact:Karen RammDirector, Business Development(651)379-5510
SOURCE ATS Labs
